Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-024033

CEO and CFO bought 174,825 shares at $14.30 ($2,499,998)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-13 Purchase : show line 1 in the form +174,825 $14.30 $2,499,998 5,525,602 D
Open-market purchases · 174,825 sh · avg $14.30 · $2,499,998
Loading xslF345X05/ownership.xml…